---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-034627"
form_type: "8-K"
ticker: "AIXC"
cik: "0001460702"
company_name: "AIxCrypto Holdings, Inc."
filed_at: "2023-09-28T23:59:59+00:00"
generated_at: "2026-06-10T07:34:08.349752+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Qualigen Therapeutics enters waiver with Alpha Capital to pay October 2023 debenture redemption in shares

## Summary
- Waiver applies to $3.3M 8% Senior Convertible Debenture issued Dec 22, 2022.
- Alpha consents to paying the October 2023 Monthly Redemption Amount in Conversion Shares.
- Alpha waives the Equity Conditions requirement for the October Payment.
- No other terms of the Debenture are amended.
- Effective September 22, 2023.

## SEC filing metadata
- accession: 0001493152-23-034627
- form_type: 8-K
- ticker: AIXC
- cik: 0001460702
- company_name: AIxCrypto Holdings, Inc.
- filed_at: 2023-09-28T23:59:59+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1460702/000149315223034627/0001493152-23-034627-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1460702/000149315223034627/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-034627
- JSON: https://secwatch.observer/filing/0001493152-23-034627.json
- Plain text: https://secwatch.observer/filing/0001493152-23-034627.txt

## Key facts
- Material Agreements
  AIxCrypto Holdings, Inc. entered into Waiver with Alpha Capital Anstalt valued at $3,300,000 (effective 2023-09-22).
  - Action: entry
  - Agreement: notes offering
  - Counterparty: Alpha Capital Anstalt
  - Value: $3,300,000
  - Effective: 2023-09-22
  source text: On September 22, 2023, Qualigen Therapeutics, Inc. (the “Company”) entered into a consent and waiver (the “Waiver”) with Alpha Capital Anstalt (“Alpha”) with respect to the 8% Senior Convertible Debenture in the aggregate principal amount of $3,300,000 issued by the Company to Alpha on December 22, 2022 (the “Debenture”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1460702/000149315223034627/0001493152-23-034627-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.